Dataset Information

SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.

ABSTRACT: The need for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) next-generation vaccines has been highlighted by the rise of variants of concern (VoCs) and the long-term threat of emerging coronaviruses. Here, we design and characterize four categories of engineered nanoparticle immunogens that recapitulate the structural and antigenic properties of the prefusion SARS-CoV-2 spike (S), S1, and receptor-binding domain (RBD). These immunogens induce robust S binding, ACE2 inhibition, and authentic and pseudovirus neutralizing antibodies against SARS-CoV-2. A spike-ferritin nanoparticle (SpFN) vaccine elicits neutralizing titers (ID₅₀ > 10,000) following a single immunization, whereas RBD-ferritin nanoparticle (RFN) immunogens elicit similar responses after two immunizations and also show durable and potent neutralization against circulating VoCs. Passive transfer of immunoglobulin G (IgG) purified from SpFN- or RFN-immunized mice protects K18-hACE2 transgenic mice from a lethal SARS-CoV-2 challenge. Furthermore, S-domain nanoparticle immunization elicits ACE2-blocking activity and ID₅₀ neutralizing antibody titers >2,000 against SARS-CoV-1, highlighting the broad response elicited by these immunogens.

SUBMITTER: Joyce MG

PROVIDER: S-EPMC8651551 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.

Joyce M Gordon MG Chen Wei-Hung WH Sankhala Rajeshwer S RS Hajduczki Agnes A Thomas Paul V PV Choe Misook M Martinez Elizabeth J EJ Chang William C WC Peterson Caroline E CE Morrison Elaine B EB Smith Clayton C Chen Rita E RE Ahmed Aslaa A Wieczorek Lindsay L Anderson Alexander A Case James Brett JB Li Yifan Y Oertel Therese T Rosado Lorean L Ganesh Akshaya A Whalen Connor C Carmen Joshua M JM Mendez-Rivera Letzibeth L Karch Christopher P CP Gohain Neelakshi N Villar Zuzana Z McCurdy David D Beck Zoltan Z Kim Jiae J Shrivastava Shikha S Jobe Ousman O Dussupt Vincent V Molnar Sebastian S Tran Ursula U Kannadka Chandrika B CB Soman Sandrine S Kuklis Caitlin C Zemil Michelle M Khanh Htet H Wu Weimin W Cole Matthew A MA Duso Debra K DK Kummer Larry W LW Lang Tricia J TJ Muncil Shania E SE Currier Jeffrey R JR Krebs Shelly J SJ Polonis Victoria R VR Rajan Saravanan S McTamney Patrick M PM Esser Mark T MT Reiley William W WW Rolland Morgane M de Val Natalia N Diamond Michael S MS Gromowski Gregory D GD Matyas Gary R GR Rao Mangala M Michael Nelson L NL Modjarrad Kayvon K

Cell reports 20211208 12

The need for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) next-generation vaccines has been highlighted by the rise of variants of concern (VoCs) and the long-term threat of emerging coronaviruses. Here, we design and characterize four categories of engineered nanoparticle immunogens that recapitulate the structural and antigenic properties of the prefusion SARS-CoV-2 spike (S), S1, and receptor-binding domain (RBD). These immunogens induce robust S binding, ACE2 inhibition, and ...[more]

PMID: 34919799

Similar Datasets

Project description:BackgroundsTo date, the effects of SARS-CoV-2 vaccines on people living with HIV (PLWH) were mainly focused on messenger RNA (mRNA) and adenovirus vector-based vaccines, and little is known about the effects of inactivated virus-based vaccine. This study was designed to determine the effects of inactivated SARS-CoV-2 vaccines on PLWH.MethodsTwenty-four HIV-positive individuals and 24 healthy donors (HD) were respectively recruited from Malipo Country People's Hospital and community in Kunming city. Enumeration of lymphocyte and CD4+CD45RO+ memory T cells were evaluated by flow cytometry. Competitive ELISA was used to measure the level of Anti-SARS-CoV-2 neutralization antibody. Spearman or Pearson correlation analysis was used to analyze the relationship between laboratory indicators and neutralization antibodies in PLWH. T-cell responses (Th1, Th2, Th17, Treg) and intracellular expression of cytokines (IL-2 and TNF-α) in CD4 or CD8 were induced by spike protein in SARS-CoV-2 (SARS-2-S) and further measured by intracellular staining.ResultsCD4, B cells, CD4+CD45RO+ memory T cells in peripheral blood of PLWH are dramatically decreased in comparison with HD. Importantly, PLWH display comparable neutralizing antibody positive rate to HD after inoculation with inactivated SARS-CoV-2 vaccine. However, PLWH showed weaker responses to vaccines exhibited by lower levels of neutralizing antibodies. Correlation analysis shows that this is possibly caused by low number of CD4 and B cells. Furthermore, SARS-2-S-induced Th2 and Th17 responses are also decreased in PLWH, while no influences on Treg and other cytokines (IL-2, TNF-α and IFN-γ) observed.ConclusionsPLWH and HD have comparable neutralizing antibodies positive rates, but PLWH display weaker responses to inactivated SARS-CoV-2 vaccines in magnitude, which suggests that a booster dose or dose adjustment are required for HIV-infected individuals, especially for those with lower counts of CD4 T and B cells.

Dataset Information

SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.

Publications

SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets